These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment with bromperidol in schizophrenic patients].
    Author: Ellerman LA.
    Journal: Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329.
    Abstract:
    The antipsychotic action, and undesirable effects of Bromperidol were examined over a 3-month period on an open clinical trial with 33 schizophrenic patients. Bromperidol was administered at an initial dose of 2.5 to 10 mg once a day. The results obtained according to BPRS and CGI parameters after 2 weeks' time, and 1, 2, and 3 months' time showed a marked improvement in most of the scored psychiatric symptoms. Bromperidol has a potent antipsychotic action and some stimulating properties on activity which make it very useful when increasing patients' motivation, and resocialization is at stake. Its general tolerance was very good. Nine patients (27%) presented mild extrapyramidal side-effects which were easily controlled with an anticholinergic medication.
    [Abstract] [Full Text] [Related] [New Search]